Jørgen Fischer Ravn
Plus aucun poste en cours
Profil
Jørgen Fischer Ravn worked as a Partner at Reliance A and as VP-Investor Relations & Communications at Bionor Pharma ASA from 2015 to 2016.
Anciens postes connus de Jørgen Fischer Ravn
Sociétés | Poste | Fin |
---|---|---|
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Investor Relations Contact | 01/09/2016 |
Reliance A/S
Reliance A/S Miscellaneous Commercial ServicesCommercial Services Reliance A/S provides business consulting services. The company also provides services to the public and initial public offering companies. It offers advices in the areas such as investor relations, corporate finance, equity research, communication and operational and strategic issues. Reliance is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Reliance A/S
Reliance A/S Miscellaneous Commercial ServicesCommercial Services Reliance A/S provides business consulting services. The company also provides services to the public and initial public offering companies. It offers advices in the areas such as investor relations, corporate finance, equity research, communication and operational and strategic issues. Reliance is headquartered in Copenhagen, Denmark. | Commercial Services |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |